Asthma and allergies strike 1 of 5 Americans, making it the most prevalent chronic disease, ranking higher than cancer, diabetes and heart disease. In fact, because more than 50 million Americans suffer from allergies it’s one of the leading causes of missed school and work.
This chronic disease has heavy cost implications to society. Allergies have an annual economic impact of $12.3 billion – $14.5 billion on direct care and $2.2 billion on indirect costs related primarily to lost work productivity.
Compounding the problem is a looming shortage of allergists in the United States; expected to decline 6.8% by 2020. Demand for allergists over the same period is expected to increase by 35%. Therefore the treatment of allergy sufferers falls to primary care providers.
Through the routine care of immunotherapy, healthcare costs can be reduced by 33%-41% in as little as 18 months. But currently, only 2-3% of patients that need IT actually receive it.
United Allergy Services (UAS) improves patients’ quality of life by empowering primary care providers and others to provide safe, effective, and customized allergy treatment throughout the United States. We exist to advance the understanding of immunotherapy (IT) as the only known disease-modifying treatment for allergies. We bring effective and convenient allergy testing and immunotherapy to providers that treat the vast majority of patients with seasonal and perennial allergies.
UAS Clinical Allergy Technicians/Specialists (CAT/CAS) work under the provider’s direct supervision to test, analyze and perform dilutions for immunotherapy treatments.
UAS works with more than 3,300 practitioners across 25 states and has already helped more than 250,000 patients break free from the confines of their symptoms and experience life without allergies.